Strs Ohio Trims Stake in Schrödinger, Inc. (NASDAQ:SDGR)

Strs Ohio decreased its stake in shares of Schrödinger, Inc. (NASDAQ:SDGR) by 27.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,500 shares of the company’s stock after selling 2,500 shares during the period. Strs Ohio’s holdings in Schrödinger were worth $232,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the stock. Sumitomo Mitsui Trust Holdings Inc. raised its stake in Schrödinger by 60.3% in the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,300,750 shares of the company’s stock valued at $82,367,000 after purchasing an additional 865,867 shares during the last quarter. Louisiana State Employees Retirement System acquired a new position in shares of Schrödinger in the fourth quarter valued at approximately $981,000. Geneos Wealth Management Inc. lifted its stake in shares of Schrödinger by 144.7% during the fourth quarter. Geneos Wealth Management Inc. now owns 21,816 shares of the company’s stock valued at $781,000 after buying an additional 12,900 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its position in Schrödinger by 5.5% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,519 shares of the company’s stock worth $878,000 after acquiring an additional 1,278 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale boosted its position in Schrödinger by 1,137.3% during the fourth quarter. DekaBank Deutsche Girozentrale now owns 248,700 shares of the company’s stock worth $9,159,000 after acquiring an additional 228,600 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Schrödinger Trading Up 2.0 %

Shares of Schrödinger stock opened at $24.44 on Tuesday. Schrödinger, Inc. has a twelve month low of $20.76 and a twelve month high of $59.24. The stock has a market cap of $1.77 billion, a price-to-earnings ratio of 38.79 and a beta of 1.57. The company has a fifty day moving average price of $26.61 and a 200 day moving average price of $28.28.

Schrödinger (NASDAQ:SDGR) last released its quarterly earnings results on Wednesday, February 28th. The company reported ($0.32) EPS for the quarter, topping the consensus estimate of ($0.44) by $0.12. Schrödinger had a negative return on equity of 23.58% and a net margin of 18.79%. The firm had revenue of $74.10 million for the quarter, compared to analyst estimates of $79.12 million. During the same period in the previous year, the company posted ($0.39) EPS. Schrödinger’s revenue for the quarter was up 30.5% on a year-over-year basis. Analysts forecast that Schrödinger, Inc. will post -2.73 earnings per share for the current year.

Insider Buying and Selling at Schrödinger

In other news, insider Robert Lorne Abel sold 1,205 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $27.55, for a total transaction of $33,197.75. Following the completion of the sale, the insider now owns 9,340 shares of the company’s stock, valued at $257,317. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, COO Kenneth Patrick Lorton sold 901 shares of the company’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $28.29, for a total value of $25,489.29. Following the sale, the chief operating officer now owns 36,487 shares in the company, valued at approximately $1,032,217.23. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Robert Lorne Abel sold 1,205 shares of Schrödinger stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $27.55, for a total value of $33,197.75. Following the completion of the transaction, the insider now owns 9,340 shares of the company’s stock, valued at $257,317. The disclosure for this sale can be found here. Insiders have sold a total of 3,651 shares of company stock valued at $102,395 in the last three months. Corporate insiders own 7.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Citigroup reduced their price target on Schrödinger from $47.00 to $39.00 and set a “buy” rating on the stock in a research note on Thursday, February 29th. Bank of America dropped their price objective on shares of Schrödinger from $38.00 to $32.00 and set a “neutral” rating for the company in a research note on Thursday, February 29th. KeyCorp decreased their target price on shares of Schrödinger from $38.00 to $33.00 and set an “overweight” rating on the stock in a research report on Thursday, February 29th. TD Cowen started coverage on shares of Schrödinger in a research report on Friday, January 26th. They set an “outperform” rating and a $42.00 price target for the company. Finally, The Goldman Sachs Group decreased their price target on shares of Schrödinger from $29.00 to $26.00 and set a “neutral” rating on the stock in a report on Friday, March 1st. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $43.50.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.